CD39-IN-1 (Compound 338) is a selective small molecule CD39 inhibitor with an IC50 value of 68.7 nM. It exhibits antiproliferative activity against tumor cells and can inhibit the eATP hydrolysis mediated by CD39 in the ATP-adenosine pathway. CD39-IN-1 shows potential for use in cancer research.
Target:
Phosphatase
* VAT and and shipping costs not included. Errors and price changes excepted